Gold Miners Gain Momentum as Prices Surge Back Past $3,010
USA News Group News Commentary Issued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, April 10, 2025 /PRNewswire/ -- USA News Group News Commentary – As tariff talks continue from the White House, gold prices rebounded back above $3,010,...
CKPower Expands RECs Operations to Accelerate Global Clean Energy Adoption
BANGKOK, March 31, 2025 /PRNewswire/ -- CK Power Public Company Limited (SET: CKP), one of Southeast Asia's largest producers of electricity from renewable sources, is expanding its Renewable Energy Certificates (RECs) business to support the...
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative cancer therapy based on membrane lipid therapy, announced today optimistic results from its ongoing clinical trial evaluating LAM561...
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued progression as planned MRX-4 Injection followed by Contezolid Tablets demonstrated favorable safety...